The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring by Gaohong Dong (4617541)

Data_Sheet_1_The Effect of Health on the Elderly's Labor Supply in Rural China: Simultaneous Equation Models With Binary, Ordered, and Censored Variables.PDF by Na Tan (10183953)

Management of consecutive cuts in the production and quality of wintergreen paspalum seeds by Rodrigo Ramos Lopes (5527421)

Metformin does not further increase the median lifespan of DR-constitutive mutant eat-2, and metformin treatment triggers several DR phenotypes in wild-type <i>C. elegans</i> witho... by Brian Onken (86790)

“…<p><b>A.</b> Survival curves of <i>eat-2(ad1116)</i> mutants raised on 0 mM, 1 mM, 10 mM, and 50 mM metformin plates at 20°C. …”

Amount and type of maternal dietary fat induced altered Pe-induced vasoconstriction in the offspring. by Christopher J. Kelsall (173702)

“…<p>Values are mean ± SD (n = 6/group) concentration which produced 50% maximum response (EC₅₀) such that increasing values on the y-axis correspond to decreasing vasoconstriction. …”

DataSheet_1_Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.pdf by Daniela Rivera-Pérez (10700565)

DataSheet1_Predicting protective gene biomarker of acute coronary syndrome by the circRNA-associated competitive endogenous RNA regulatory network.docx by Hengliang Zhang (13980072)

“…The circRNA-miRNA and miRNA-mRNA regulatory links were retrieved from the CircInteractome database and TargetScan databases, respectively. As a final step, a regulatory network has been designed for ceRNA. …”

Circular Dichroism analysis, PPIase activity and nickel regulation of <i>H</i>. <i>pylori</i> WT and mutant SlyD proteins. by Milica Denic (9987685)

Optimal hydrated lime concentration in asphalt binder to improve photo degradation resistance by André Gustavo Banja (5110844)

Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-I<i>α</i> by Lin Li (28817)

“…The activation of PKG–1α was then studied using targeted proteomic analysis (MRM-MS) checking the phosphorylation state of the autophosphorylation domain (aa42-94). Significant decrease in phosphorylation of PKG-Iα at Ser50, Ser72, Ser89 was induced by HR injury while SCU treatment significantly increased the phosphorylation of PKG-Iα, not only at Ser50, Ser72 and Ser89, but also at Ser44 and Thr58 (two novel phosphorylation domains). …”

Histone deacetylase (HDAC) inhibitor assessment. by Ilona Tkachyova (343715)

“…ITF 2357, an HDAC inhibitor which is structurally and functionally similar to SAHA, produced a dose-response curve with IC₅₀ of 0.2 μM. …”

Plk1 inhibition suppresses the clonogenic potential of SUM149 and SUM159. by Antonio Giordano (55096)

“…(B) EC₅₀ was defined as 50% colony inhibition. Single agents EC₅₀ were reported for each TNBC cell line and drug. …”

Regulation of MCF-7 mammosphere formation by breast cancer promoters and metformin. by Ji-Won Jung (194917)

“…On the other hand, metformin treatment decreased MCF-7 proliferation (mean ± SD, n = 3). *, <i>P</i><0.05; **, <i>P</i><0.01; ***, <i>P</i><0.001. …”

Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”